Contafever N Syrup is one of the medicines classified in the classification of drug safety classes for pregnant women in Category C, and practical practices indicate that the components of Contafever N (ibuprofen) are not expected to cause any significant harm to the pregnancy or to the fetus, but the safety of this has not been confirmed. Use during pregnancy. Therefore, it is recommended to avoid the use of Contafever N syrup during pregnancy, whenever possible, especially in the first trimester of pregnancy. If you are pregnant, you should consult your doctor before using Contafever N and caution should be taken by weighing the potential benefit of treating the mother against any harm that may occur to the fetus.